StingMed Insect bites Skin Protectant. Zinc acetate (.1% by volume), 0.3 fl. oz. (3 mL) bottle, P...

FDA Drug Recall #D-0950-2017 — Class II — June 8, 2017

Recall Summary

Recall Number D-0950-2017
Classification Class II — Moderate risk
Date Initiated June 8, 2017
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Phillips Co.
Location Millerton, OK
Product Type Drugs
Quantity 20-50 bottles/units

Product Description

StingMed Insect bites Skin Protectant. Zinc acetate (.1% by volume), 0.3 fl. oz. (3 mL) bottle, Phillips Company, Millerton, OK -- NDC 04307-100-11

Reason for Recall

GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Distribution Pattern

Nationwide and United Kingdom

Lot / Code Information

All lots remaining within expiry.

Other Recalls from Phillips Co.

Recall # Classification Product Date
D-0948-2017 Class II TetraStem brand Topical Ointment First Aid Anti... Jun 8, 2017
D-0951-2017 Class II StaphWash+Plus+ Skin Protectant, Zinc acetate (... Jun 8, 2017
D-0952-2017 Class II VenomX, Zinc acetate (.1% by volume), 0.3 fl. o... Jun 8, 2017
D-0947-2017 Class II Tetracycline-ABC Brand Topical ointment First A... Jun 8, 2017
D-0949-2017 Class II Diabecline brand Topical Ointment First Aid Ant... Jun 8, 2017

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.